WHO ICTRP trial

DEVELOPMENT and VALIDATION of a SCORE to IDENTIFY OLDER ADULTS at RISK of…

NL-OMON32352 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting

Key facts

Trial ID NL-OMON32352
Public title DEVELOPMENT and VALIDATION of a SCORE to IDENTIFY OLDER ADULTS at RISK of ADVERSE DRUG REACTIONS: An international multicenter study.
Scientific title DEVELOPMENT and VALIDATION of a SCORE to IDENTIFY OLDER ADULTS at RISK of ADVERSE DRUG REACTIONS: An international multicenter study. - ADR risk score
Primary sponsor Erasmus MC, Universitair Medisch Centrum Rotterdam
Registry Overview of Medical Research in the Netherlands (NL-OMON)
Recruitment status Recruiting
Study type Observational non invasive
Countries The Netherlands
Conditions risico-inschatting van risico op geneesmiddelbijwerkingen bij ouderen adverse drug reactions side effects of drugs;adverse drug reactions;side effects of drugs
Interventions ;drugs;older adults;risk score
Registration date Nov 11, 2008
Target size 150
Secondary IDs NL23547.078.08
Registry page onderzoekmetmensen.nl

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations